CAS: 184766-45-8; 2-Methyl-5-(2-Methyl-1,3-Dioxolan-2-yl)Pyridine

该化合物是一种七环化合物,其特点是在6位置用一甲基组替代六位置的核心和在3位置以二甲基-1,3-二氧基辛基,这种结构具有稳定性和反应性,使其成为有机合成中的宝贵中间体,特别是制药和农用化学品.二酚组提高了溶性,并有可能进一步发挥作用,而环则有助于其协调化学的用途.其定义明确的分子结构确保了交叉组合反应和其他变异的一贯性能.对于受控制的环境来说,这种复合体的特点是在标准储存条件下具有很高的纯性和稳定性.

结构式图片

MSDS等安全信息

    上下游产品

    CAS号36357-38-7 5-乙酰基-2-甲基嘧啶 | CAS号107-21-1 乙二醇 | CAS号5470-70-2 6-甲基烟酸甲酯 | CAS号21683-58-9 ethyl 3-(2-meth... | CAS号184766-50-5 5-(2-甲基-1,3-二氧杂... | CAS号184766-55-0 4-[2-(5-(2-METH... | CAS号184766-66-3 5-[4-[2-[5-(2-M...

    合成工艺路线路线简述

    • 合成目标产物 3-(2-Methyl-1,3-Dioxolan-2-yl)-6-Methylpyridine 主要起始原料 5-Acetyl-2-Methylpyridine And Ethylene Glycol
    • (文献来源)合成步骤主要原料 5-Acetyl-2-Methylpyridine 和 Ethylene Glycol
    📜6-甲基烟酸甲酯置于硫酸,Sodium Hydride,对甲苯磺酸体系中,用 N,N-二甲基甲酰胺,甲苯 用作溶剂,化学反应 12.5H,反应生成3-(2-甲基-1,3-二氧戊烷-yl)-6-甲基吡啶
    参考文献:Synthesis And Biological Activity Of Metabolites Of The Antidiabetic,Antihyperglycemic Agent Pioglitazone
    标题:Synthesis And Biological Activity Of Metabolites Of The Antidiabetic,Antihyperglycemic Agent Pioglitazone
    摘要:Pioglitazone (5-(4-(2-(5-Ethyl-2-Pyridyl)Ethoxy)Benzyl)-2,4-Thiazolidinedione,2) Is A Prototypical Antidiabetic Thiazolidinedione That Had Been Evaluated For Possible; Clinical Development. Metabolites 6-9 Have Been Identified After Dosing Of Rats And Dogs. Ketone 10 Has Not Yet Been Identified As A Metabolite But Has Been Added To The List As A Putative Metabolite By Analogy To Alcohol 6 And Ketone 7. We Have Developed Improved Syntheses Of Pioglitazone (2) Metabolites 6-9 And The Putative Metabolite Ketone 10. These Entities Have Been Compared In The Kka(Y) Mouse Model Of Human Type-Ii Diabetes To Pioglitazone (2). Ketone 10 Has Proven To Be The Most Potent Of These Thiazolidinediones In This In,Vivo Assay. When 6-10 Were Compared In Vitro In The 3T3-L1 Cell Line To 2,For Their Ability To Augment Insulin-Stimulated Lipogenesis,10 Was Again The Most Potent Compound With 6,7,And 9 Roughly Equivalent To 2. These Data Suggest That Metabolites 6,7,And 9 Are Likely To Contribute To The Pharmacological Activity Of Pioglitazone (2),As Had Been Previously Reported For Ciglitazone (1).
    Doi:10.1021/jm9605694

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1021/jm9605694
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知